Insmed | INSM - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
BioMarin Pharmaceutical USD 395.55M 137.27M 2026-06
Cytokinetics USD 104.4M 499K 2026-06
DBV Technologies USD 13.4M 8.14M 2026-03
Gilead Sciences USD 1.52B 70M 2026-06
Heron Therapeutics USD 23.74M 605K 2025-12
Insmed USD 247.47M 208K 2026-06
Novartis USD 3.14B 296M 2026-03
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06